Bridgefront Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-14,882
Closed -$405K – 479
2022
Q4
$405K Buy
+14,882
New +$681K 0.28% 136
2021
Q1
– Sell
-2,075
Closed -$267K – 765
2020
Q4
$267K Buy
+2,075
New +$239K 0.09% 416

Other funds holding GH

Bridgefront Capital's GH Position: Q1 2023 in Review

Bridgefront Capital sold out of Guardant Health (GH) in Q1 2023, closing a stake of 14,882 shares — an estimated $405K sold.

Bridgefront Capital first reported a position in GH in Q4 2020 and held it in 2 quarters. The position peaked at $405K in Q4 2022. 279 funds tracked by Wall St. Rank hold GH as of Q1 2023.

  • Bridgefront Capital reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
  • Bridgefront Capital sold 14,882 Guardant Health shares in Q1 2023, an estimated $405K.
  • Bridgefront Capital first reported a position in Guardant Health in Q4 2020 and held it in 2 quarters.
  • Bridgefront Capital's Guardant Health position peaked at $405K in Q4 2022.
  • 279 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on Bridgefront Capital's 13F filing for Q1 2023, filed 15 May 2023.